Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate and Severe COVID-19”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 18 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT04565665
What this trial is testing

Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia

Who this might be right for
COVID-19 InfectionCOVID-19-Associated Acute Respiratory Distress SyndromeHematopoietic and Lymphoid Cell Neoplasm+2 more
M.D. Anderson Cancer Center 65
Large-scale testing (Phase 3)Ended earlyNCT05279235
What this trial is testing

Efficacy and Safety of JT001 (VV116) Compared With Favipiravir

Who this might be right for
Moderate to Severe COVID-19
Shanghai Vinnerna Biosciences Co., Ltd. 290
Not applicableUnknownNCT04429711
What this trial is testing

Ivermectin vs. Placebo for the Treatment of Patients With Mild to Moderate COVID-19

Who this might be right for
COVID-19
Sheba Medical Center 100
Testing effectiveness (Phase 2)Ended earlyNCT05195749
What this trial is testing

A Prospective, Phase II Study to Evaluate Safety of 101-PGC-005 ('005) for Moderate to Severe COVID-19 Disease Along With Standard of Care

Who this might be right for
COVID-19
101 Therapeutics 3
Early research (Phase 1)Ended earlyNCT04762186
What this trial is testing

Viable Human SARS-CoV-2 Specific T Cell Transfer in Patients at Risk for Severe COVID-19

Who this might be right for
Moderate COVID-19-infection
Universitätsklinikum Köln 1
Testing effectiveness (Phase 2)WithdrawnNCT04561180
What this trial is testing

Study to Evaluate the Efficacy and Safety of EG-009A Compared to DEX in Patients With COVID-19 Pneumonia

Who this might be right for
COVID-19 Pneumonia
Evergreen Therapeutics, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT04373044
What this trial is testing

Baricitinib, Placebo and Antiviral Therapy for the Treatment of Patients With Moderate and Severe COVID-19

Who this might be right for
Symptomatic COVID-19 Infection Laboratory-Confirmed
University of Southern California 6
Not applicableUnknownNCT05665205
What this trial is testing

Benefits of an Aerobic and Strength Rehabilitation Program With Post- SARS-CoV-2 Patients Moderate-severe

Who this might be right for
COVID-19
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 20
Testing effectiveness (Phase 2)Ended earlyNCT04416048
What this trial is testing

Effect of Anticoagulation Therapy on Clinical Outcomes in COVID-19

Who this might be right for
COVID-19
Charite University, Berlin, Germany 111
Early research (Phase 1)Ended earlyNCT05487040
What this trial is testing

Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease

Who this might be right for
COVID-19
Pfizer 15
Not applicableStudy completedNCT04349618
What this trial is testing

Ultraprotective Ventilation Without Extracorporeal Circulation During COVID 19 Pneumonia

Who this might be right for
Acute Respiratory Distress SyndromeCOVID19Sars-CoV2+1 more
Hospices Civils de Lyon 220
Early research (Phase 1)Study completedNCT04435522
What this trial is testing

Maraviroc in Patients With Moderate and Severe COVID-19

Who this might be right for
COVID
Rhode Island Hospital 9
Testing effectiveness (Phase 2)Ended earlyNCT05226533
What this trial is testing

Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.

Who this might be right for
COVID-19
Daewoong Pharmaceutical Co. LTD. 1
Large-scale testing (Phase 3)UnknownNCT05096052
What this trial is testing

PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19

Who this might be right for
COVID-19COVID-19 PandemicCOVID-19 Respiratory Infection+2 more
Bioxytran Inc. 408
Not applicableStudy completedNCT04492501
What this trial is testing

Investigational Treatments for COVID-19 in Tertiary Care Hospital of Pakistan

Who this might be right for
Covid19Cytokine Release SyndromeCritical Illness+1 more
UNICEF 600
Post-approval studies (Phase 4)UnknownNCT04359316
What this trial is testing

Azithromycin in Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
Shahid Beheshti University of Medical Sciences 40
Large-scale testing (Phase 3)Study completedNCT04358081
What this trial is testing

Hydroxychloroquine Monotherapy and in Combination With Azithromycin in Patients With Moderate and Severe COVID-19 Disease

Who this might be right for
Covid-19
Novartis Pharmaceuticals 20
Testing effectiveness (Phase 2)Study completedNCT04392414
What this trial is testing

Hyperimmune Convalescent Plasma in Moderate and Severe COVID-19 Disease

Who this might be right for
COVID-19
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia 60